4.7 Article

Design of Novel BSA/Hyaluronic Acid Nanodispersions for Transdermal Pharma Purposes

Journal

MOLECULAR PHARMACEUTICS
Volume 11, Issue 5, Pages 1479-1488

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/mp400657g

Keywords

hyaluronic acid; bovine serum albumin; nanodispersion; transdermal transport; skin penetration

Funding

  1. Fundacao para a Ciencia e a Tecnologia [SFRH/BPD/46515/2008, SFRH/BPD/47555/2008]
  2. Fundação para a Ciência e a Tecnologia [SFRH/BPD/47555/2008] Funding Source: FCT

Ask authors/readers for more resources

A novel transdermal hyaluronic acid (HA) conjugated with bovine serum albumin (BSA) was developed in the form of solid-in-oil (S/O) nanodispersion (129.7 nm mean diameter). Ex vivo skin penetration analysis by fluorescence and confocal observation of histological skin sections revealed the ability of BSA/HA nanodispersions to cross the stratum corneum and penetrate into the dermis. Furthermore, no significant toxicity was found in fibroblast and keratinocyte cells in vitro. These results proved the potential of the developed nanodispersion for transdermal delivery of hyaluronic acid constituting a high value to biopharmaceutical and cosmetics industries.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available